speb/financial-data huggingface dataset:
Financial ratios for BIAF — annual report dated 2024-12-31
Total revenue: 9362022
Gross profit: 3378547
Operating income: -8953445
Net income: -9039831
Capital expenditures: 79083
Operating cash flow: -7264795
Depreciation & amortization: 605637
Net tangible assets: 422411
Owner earnings: -8513277
Return on net tangible assets (%): -2015.4013508170951
Buffett classification: The Gruesome
Stock price: 27.3
Shares outstanding: 6283061
Book value: 2602036
P/B ratio: 65.92051966229522
Market cap (USD): 171527565.3
Debt to equity: 0.576930526710622
Current ratio: 0.8680130309945071
Quick ratio: 0.8591212935661477
Interest coverage ratio: -96.82016761286835
COGS to revenue (%): 63.912208281501584
R&D to revenue (%): 19.04377067261752
SG&A to revenue (%): 106.21074165388632
Free cash flow (dilution-adjusted): -8333559
Buyback yield (%): 0
Retained earnings: -53644310
Inventory turnover: 216.72975224572588
Receivables turnover: 8.218038209135502
Capitalized R&D asset: 3441338.0900000003
ROCI (R&D-adjusted, %): -129.16277451550835
Rosenberg metric: 1.5000211643647763
FCF margin (%): -89.01452058113087
Revenue growth (%): 269.67524962497515
Rule of 40 score: 180.6607290438443
Financial ratios for BIAF — quarterly report dated 2024-12-31
Capital expenditures: 1
Buffett classification: The Gruesome
Stock price: 27.3
Shares outstanding: 6283061
Market cap (USD): 171527565.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIAF — quarterly report dated 2025-03-31
Total revenue: 1853597
Gross profit: 485737
Operating income: -2627139
Net income: -2660417
Capital expenditures: 50786
Operating cash flow: -1641775
Depreciation & amortization: 154588
Net tangible assets: -725638
Owner earnings: -2556615
Buffett classification: The Gruesome
Stock price: 7.8
Shares outstanding: 6283061
Book value: 1439404
P/B ratio: 34.0473388985997
Market cap (USD): 49007875.8
Debt to equity: 0.9248008203395294
Current ratio: 0.5456980408495732
Quick ratio: 0.5343430318301556
Interest coverage ratio: -169.6570229254117
COGS to revenue (%): 73.79489716480983
R&D to revenue (%): 27.284193921332417
SG&A to revenue (%): 132.31295691566183
Free cash flow (dilution-adjusted): -2019177
Buyback yield (%): 0
Retained earnings: -56304727
Inventory turnover: 35.27048630808107
Receivables turnover: 1.9233292243583358
Capitalized R&D asset: 505739
ROCI (R&D-adjusted, %): -86.82015392958203
FCF margin (%): -108.93290181199042
Rule of 40 score: -108.93290181199042
Financial ratios for BIAF — quarterly report dated 2025-06-30
Total revenue: 1269483
Gross profit: 252881
Operating income: -2515560
Net income: -4060787
Capital expenditures: 13427
Operating cash flow: -2647206
Depreciation & amortization: 113229
Net tangible assets: -4286566
Owner earnings: -3960985
Buffett classification: The Gruesome
Stock price: 8.61
Shares outstanding: 6283061
Book value: -2136108
Market cap (USD): 54097155.20999999
Debt to equity: -0.31365314862357146
Current ratio: 0.6447565664620539
Quick ratio: 0.6277682219708349
Interest coverage ratio: -240.49330783938814
COGS to revenue (%): 80.08000107130225
R&D to revenue (%): 34.711059541561404
SG&A to revenue (%): 174.4458964791179
Free cash flow (dilution-adjusted): -2872240
Buyback yield (%): 0
Retained earnings: -60365514
Inventory turnover: 23.11982897819017
Receivables turnover: 3.0091876862248705
Capitalized R&D asset: 779496.13
ROCI (R&D-adjusted, %): -81.24253263616257
Rosenberg metric: -0.46042721641004547
FCF margin (%): -226.2527343808464
Revenue growth (%): -31.512459288615595
Rule of 40 score: -257.765193669462
Financial ratios for BIAF — quarterly report dated 2025-09-30
Total revenue: 1446066
Gross profit: 503855
Operating income: -2292846
Net income: -5051084
Capital expenditures: 3646
Operating cash flow: -2480298
Depreciation & amortization: 113360
Net tangible assets: 6766323
Owner earnings: -4941370
Return on net tangible assets (%): -73.02888141757347
Buffett classification: The Gruesome
Stock price: 2.96
Shares outstanding: 6283061
Book value: 8902198
P/B ratio: 2.0891313089194377
Market cap (USD): 18597860.56
Debt to equity: 0.07649212026063676
Current ratio: 3.6504935426875966
Quick ratio: 3.635561179925351
Interest coverage ratio: -427.92945128779394
COGS to revenue (%): 65.15684622970183
R&D to revenue (%): 32.77167155579344
SG&A to revenue (%): 152.7897758470222
Free cash flow (dilution-adjusted): -2543784
Buyback yield (%): 0
Retained earnings: -65416598
Inventory turnover: 26.741528069478345
Receivables turnover: 3.220708701752823
Capitalized R&D asset: 936030.04
ROCI (R&D-adjusted, %): -22.64561290435848
Rosenberg metric: 0.5695527753255978
FCF margin (%): -175.91064308268088
Revenue growth (%): 13.909835736280044
Rule of 40 score: -162.00080734640085
Financial ratios for BIAF — annual report dated 2025-12-31
Total revenue: 6107959
Gross profit: 1881160
Operating income: -10626508
Net income: -14909754
Capital expenditures: 60568
Operating cash flow: -9328842
Depreciation & amortization: 504836
Net tangible assets: 5156364
Owner earnings: -14465486
Return on net tangible assets (%): -280.53655637965045
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 6283061
Book value: 7277656
P/B ratio: 1.0187362496935826
Market cap (USD): 7414011.9799999995
Debt to equity: 0.15950479110306945
Current ratio: 2.603157562231476
Quick ratio: 2.5847319113911595
Interest coverage ratio: -239.4867934733616
COGS to revenue (%): 69.20149594979273
R&D to revenue (%): 34.202963706861816
SG&A to revenue (%): 162.30837502347347
Free cash flow (dilution-adjusted): -10060884
Buyback yield (%): 0
Retained earnings: -68554064
Inventory turnover: 78.93476880555762
Receivables turnover: 11.270087201685728
Capitalized R&D asset: 3852750.95
ROCI (R&D-adjusted, %): -87.36558731728735
Rosenberg metric: -0.8398688191366562
FCF margin (%): -164.717608615251
Revenue growth (%): -34.75812169636004
Rule of 40 score: -199.47573031161104
Financial ratios for BIAF — quarterly report dated 2025-12-31
Total revenue: 1538813
Gross profit: 638687
Operating income: -3190963
Net income: -3137466
Capital expenditures: 1
Operating cash flow: -2559563
Depreciation & amortization: 123659
Net tangible assets: 5156364
Owner earnings: -3013808
Return on net tangible assets (%): -58.448317457805544
Buffett classification: The Gruesome
Stock price: 1.18
Shares outstanding: 6283061
Book value: 7277656
P/B ratio: 1.0187362496935826
Market cap (USD): 7414011.9799999995
Debt to equity: 0.15950479110306945
Current ratio: 2.603157562231476
Quick ratio: 2.5847319113911595
Interest coverage ratio: -244.1627515494682
COGS to revenue (%): 58.49482685680456
R&D to revenue (%): 43.462915896863365
SG&A to revenue (%): 197.37148048528314
Free cash flow (dilution-adjusted): -2625683
Buyback yield (%): 0
Retained earnings: -68554064
Inventory turnover: 16.80970344363935
Receivables turnover: 2.839337444322665
Capitalized R&D asset: 1131740.83
ROCI (R&D-adjusted, %): -33.20077127982767
Rosenberg metric: 0.28451572061616376
FCF margin (%): -170.6304144818116
Revenue growth (%): 6.413745983931578
Rule of 40 score: -164.21666849788002
Financial ratios for BPAC11.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.2754385964912283
Shares outstanding: 3342095256
Market cap (USD): 10946827794.652632
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPAC11.SA — annual report dated 2022-12-31
Total revenue: 5568240151.515151
Net income: 1560664204.5454545
Capital expenditures: 52495454.54545454
Operating cash flow: 4148000189.393939
Depreciation & amortization: 157891287.87878788
Net tangible assets: 7134162878.787878
Owner earnings: 1666060037.878788
Return on net tangible assets (%): 23.35326605497768
Buffett classification: The Gruesome
Stock price: 4.166982922201139
P/E ratio: 8.923414668934207
Shares outstanding: 3342095256
Book value: 8828278598.484848
P/B ratio: 1.5774823710832564
Market cap (USD): 13926453856.121445
Debt to equity: 1.598419837629642
Effective tax rate (%): 13.309885110836028
COGS to revenue (%): 0
SG&A to revenue (%): 20.969161275453306
Free cash flow (dilution-adjusted): 3849964583.333333
Buyback yield (%): 0.31449303408617374
Receivables turnover: 0.4125908034080429
Capitalized R&D asset: 0
FCF margin (%): 69.14149674894561
Rule of 40 score: 69.14149674894561
Financial ratios for BPAC11.SA — annual report dated 2023-12-31
Total revenue: 6645281443.298969
Net income: 2129114432.9896908
Capital expenditures: 28489484.536082476
Operating cash flow: -3848365360.8247423
Depreciation & amortization: 204218556.70103094
Net tangible assets: 9307401443.29897
Owner earnings: 2304843505.1546392
Return on net tangible assets (%): 24.763555318805473
Buffett classification: The Gruesome
Stock price: 7.331262939958592
P/E ratio: 11.50796721513881
Shares outstanding: 3342095256
Book value: 11038240824.742264
P/B ratio: 2.2197177504230003
Market cap (USD): 24501779092.12422
Debt to equity: 0.7042356667172502
Effective tax rate (%): 10.977839496895344
COGS to revenue (%): 0
SG&A to revenue (%): 22.558314767334327
Free cash flow (dilution-adjusted): -3958504123.7113404
Buyback yield (%): 0.25344340954350353
Receivables turnover: 0.8542327779525903
Capitalized R&D asset: 0
FCF margin (%): -59.568645173080725
Revenue growth (%): 19.342579746506605
Rule of 40 score: -40.226065426574124
Financial ratios for BPAC11.SA — quarterly report dated 2024-09-30
Capital expenditures: 37722467.77163904
Buffett classification: The Gruesome
Stock price: 5.867403314917127
Shares outstanding: 3342095256
Market cap (USD): 19609420783.823204
Buyback yield (%): 0
Retained earnings: 565061694.290976
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPAC11.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.252019386106624
Shares outstanding: 3342095256
Market cap (USD): 14210653818.72698
Buyback yield (%): 0.11561019366782548
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPAC11.SA — annual report dated 2024-12-31
Total revenue: 6113785275.080907
Net income: 1987268770.2265372
Capital expenditures: 39717475.728155345
Operating cash flow: 474862944.98381877
Depreciation & amortization: 182545145.63106796
Net tangible assets: 8626082200.64725
Owner earnings: 2130096440.1294496
Return on net tangible assets (%): 24.693671942630225
Buffett classification: The Gruesome
Stock price: 4.252019386106624
P/E ratio: 7.150846443939764
Shares outstanding: 3342095256
Book value: 10280561488.673141
P/B ratio: 1.3822838212080062
Market cap (USD): 14210653818.72698
Debt to equity: 0.6654574638692715
Effective tax rate (%): 13.345766899574949
COGS to revenue (%): 0
SG&A to revenue (%): 22.474087883467124
Free cash flow (dilution-adjusted): 370085598.7055016
Buyback yield (%): 0.11561019366782548
Receivables turnover: 0.413863353650284
Capitalized R&D asset: 0
FCF margin (%): 6.053297295440329
Revenue growth (%): -7.998098692328787
Rule of 40 score: -1.944801396888458
Financial ratios for BPAC11.SA — quarterly report dated 2025-03-31
Total revenue: 2004033333.3333335
Net income: 592231250
Capital expenditures: 22374479.166666668
Operating cash flow: -1961995659.7222223
Depreciation & amortization: 54277256.94444445
Net tangible assets: 9522791493.055555
Owner earnings: 624134027.7777778
Return on net tangible assets (%): 6.554107881422419
Buffett classification: The Gruesome
Stock price: 5.694444444444444
P/E ratio: 8.033760361063914
Shares outstanding: 3342095256
Book value: 11364810763.888885
P/B ratio: 1.6745880031548408
Market cap (USD): 19031375763.333332
Debt to equity: 0.6882352644638492
Effective tax rate (%): 17.04529170946894
COGS to revenue (%): 0
SG&A to revenue (%): 18.384270540521058
Free cash flow (dilution-adjusted): -2166423090.2777777
Buyback yield (%): 0
Retained earnings: 557277777.7777778
Receivables turnover: 25.75091073360624
Capitalized R&D asset: 0
FCF margin (%): -108.10314650177695
Rule of 40 score: -108.10314650177695
Financial ratios for BPAC11.SA — quarterly report dated 2025-06-30
Total revenue: 2283559124.087591
Net income: 762583394.1605839
Capital expenditures: 5242518.248175182
Operating cash flow: -4451809671.532846
Depreciation & amortization: 53110036.49635036
Net tangible assets: 10732894890.510948
Owner earnings: 810450912.4087591
Return on net tangible assets (%): 7.551093350641926
Buffett classification: The Gruesome
Stock price: 7.503649635036496
P/E ratio: 18.510216106705414
Shares outstanding: 3342095256
Book value: 12727924452.554749
P/B ratio: 1.9703064660246286
Market cap (USD): 25077911847.941605
Debt to equity: 0.7659056342951654
Effective tax rate (%): 9.297710475699672
COGS to revenue (%): 0
SG&A to revenue (%): 19.07640493326463
Free cash flow (dilution-adjusted): -4490126824.817518
Buyback yield (%): 0
Receivables turnover: 21.481732490811744
Capitalized R&D asset: 0
FCF margin (%): -196.6284462466709
Revenue growth (%): 13.948160746873356
Rule of 40 score: -182.68028549979755
Financial ratios for BPAC11.SA — quarterly report dated 2025-09-30
Total revenue: 2635826503.7593985
Net income: 871020864.6616541
Capital expenditures: 5941541.353383458
Operating cash flow: 1844008082.7067668
Depreciation & amortization: 49375000
Net tangible assets: 11450754699.24812
Owner earnings: 914454323.3082707
Return on net tangible assets (%): 7.985974263934898
Buffett classification: The Gruesome
Stock price: 8.960526315789474
P/E ratio: 13.454243304398112
Shares outstanding: 3342095256
Book value: 13653510338.345856
P/B ratio: 2.193350409466294
Market cap (USD): 29946932491.26316
Debt to equity: 0.735024971889201
Effective tax rate (%): 17.3563835530312
COGS to revenue (%): 0
SG&A to revenue (%): 17.213822803293855
Free cash flow (dilution-adjusted): 1837701127.8195488
Buyback yield (%): 0.06825670535587473
Retained earnings: 382965601.5037594
Receivables turnover: 30.7808074843655
Capitalized R&D asset: 0
FCF margin (%): 69.72010962020802
Revenue growth (%): 15.426243006191385
Rule of 40 score: 85.1463526263994
Financial ratios for BPAC11.SA — quarterly report dated 2025-12-31
Total revenue: 2534153102.1897807
Net income: 827785583.9416058
Capital expenditures: 24021167.883211676
Operating cash flow: 258945437.95620435
Depreciation & amortization: 54937773.72262774
Net tangible assets: 11522408576.642334
Owner earnings: 858702189.7810218
Return on net tangible assets (%): 7.452453921151009
Buffett classification: The Gruesome
Stock price: 9.439856373429084
P/E ratio: 10.331635210969702
Shares outstanding: 3342095256
Book value: 14034700000
P/B ratio: 2.2479211670330472
Market cap (USD): 31548899202.958706
Debt to equity: 0.9198995903739942
Effective tax rate (%): 3.7557972310910492
COGS to revenue (%): 0
SG&A to revenue (%): 19.37727507836556
Free cash flow (dilution-adjusted): 178097627.73722628
Buyback yield (%): 0.009688933376575153
Receivables turnover: 0.6521852699676559
Capitalized R&D asset: 0
FCF margin (%): 7.027895338420191
Revenue growth (%): -3.857363199914869
Rule of 40 score: 3.1705321385053225
Financial ratios for BPAC11.SA — annual report dated 2025-12-31
Total revenue: 9483009489.051094
Net income: 3058449817.518248
Capital expenditures: 48064416.05839416
Operating cash flow: -4501678832.116788
Depreciation & amortization: 208439963.50364962
Net tangible assets: 11522408576.642334
Owner earnings: 3218825364.963504
Return on net tangible assets (%): 27.93535174137593
Buffett classification: The Gruesome
Stock price: 9.439856373429084
P/E ratio: 10.315323476047347
Shares outstanding: 3342095256
Book value: 14034700000
P/B ratio: 2.2479211670330472
Market cap (USD): 31548899202.958706
Debt to equity: 0.9198995903739942
Effective tax rate (%): 11.921689932477102
COGS to revenue (%): 0
SG&A to revenue (%): 18.50047141553126
Free cash flow (dilution-adjusted): -4841839233.576642
Buyback yield (%): 0.06349256197719724
Receivables turnover: 2.4405309601769534
Capitalized R&D asset: 0
FCF margin (%): -51.058044802833315
Revenue growth (%): 55.10864484728899
Rule of 40 score: 4.050600044455678
Financial ratios for BPRN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.82
Shares outstanding: 6811150
Market cap (USD): 169052743
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPRN — annual report dated 2022-12-31
Total revenue: 72945000
Net income: 26494000
Capital expenditures: 607000
Operating cash flow: 23987000
Depreciation & amortization: 2051000
Net tangible assets: 208923000
Owner earnings: 27938000
Return on net tangible assets (%): 13.372390785121791
Buffett classification: The Gruesome
Stock price: 27.74
P/E ratio: 7.131475088699327
Shares outstanding: 6811150
Book value: 219601000
P/B ratio: 0.8603845201069211
Market cap (USD): 188941301
Debt to equity: 0.12191201315112409
Effective tax rate (%): 22.197750565295273
COGS to revenue (%): 0
SG&A to revenue (%): 30.08979368016999
Free cash flow (dilution-adjusted): 23336000
Buyback yield (%): 4.985675418843443
Retained earnings: 131488000
Receivables turnover: 15.337468460891506
Capitalized R&D asset: 0
FCF margin (%): 31.991226266365068
Rule of 40 score: 31.991226266365068
Financial ratios for BPRN — annual report dated 2023-12-31
Total revenue: 72238000
Net income: 25765000
Capital expenditures: 1712000
Operating cash flow: 23112000
Depreciation & amortization: 1978000
Net tangible assets: 229936000
Owner earnings: 26031000
Return on net tangible assets (%): 11.3209762716582
Buffett classification: The Gruesome
Stock price: 32.66
P/E ratio: 8.633889346012031
Shares outstanding: 6811150
Book value: 240211000
P/B ratio: 0.9260698261112106
Market cap (USD): 222452158.99999997
Debt to equity: 0.1010778024320285
Effective tax rate (%): 15.065106312839955
COGS to revenue (%): 0
SG&A to revenue (%): 34.30465959744179
Free cash flow (dilution-adjusted): 20593000
Buyback yield (%): 0
Retained earnings: 149414000
Receivables turnover: 11.863688618820824
Capitalized R&D asset: 0
FCF margin (%): 28.507156898031504
Revenue growth (%): -0.9692233874837206
Rule of 40 score: 27.537933510547784
Financial ratios for BPRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.59
Shares outstanding: 6811150
Market cap (USD): 235597678.50000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPRN — annual report dated 2024-12-31
Total revenue: 74687000
Net income: 10242000
Capital expenditures: 1525000
Operating cash flow: 14730000
Depreciation & amortization: 2283000
Net tangible assets: 244027000
Owner earnings: 11000000
Return on net tangible assets (%): 4.507697918672934
Buffett classification: The Gruesome
Stock price: 32.47
P/E ratio: 21.59324746143331
Shares outstanding: 6811150
Book value: 262040000
P/B ratio: 0.843985805602198
Market cap (USD): 221158040.5
Debt to equity: 0.0875477026408182
Effective tax rate (%): 20.084269662921347
COGS to revenue (%): 0
SG&A to revenue (%): 37.23807356032509
Free cash flow (dilution-adjusted): 12192000
Buyback yield (%): 0.38072321408544946
Retained earnings: 151915000
Receivables turnover: 9.365141065830722
Capitalized R&D asset: 0
FCF margin (%): 16.324126019253686
Revenue growth (%): 3.3901824524488497
Rule of 40 score: 19.714308471702537
Financial ratios for BPRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.47
Shares outstanding: 6811150
Market cap (USD): 221158040.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BPRN — quarterly report dated 2025-03-31
Total revenue: 20947000
Net income: 5378000
Capital expenditures: 200000
Operating cash flow: 1251000
Depreciation & amortization: 673000
Net tangible assets: 249203000
Owner earnings: 5851000
Return on net tangible assets (%): 2.3478850575635124
Buffett classification: The Gruesome
Stock price: 29.08
P/E ratio: 9.207337393082929
Shares outstanding: 6811150
Book value: 266987000
P/B ratio: 0.7418647424780981
Market cap (USD): 198068242
Debt to equity: 0.083303681452655
Effective tax rate (%): 21.91084652243357
COGS to revenue (%): 0
SG&A to revenue (%): 37.599656275361625
Free cash flow (dilution-adjusted): 750000
Buyback yield (%): 0.08229486885636113
Retained earnings: 155170000
Receivables turnover: 2.5714461085195186
Capitalized R&D asset: 0
FCF margin (%): 3.5804649830524657
Rule of 40 score: 3.5804649830524657
Financial ratios for BPRN — quarterly report dated 2025-06-30
Total revenue: 21061000
Net income: 688000
Capital expenditures: 251000
Operating cash flow: 3142000
Depreciation & amortization: 668000
Net tangible assets: 244380000
Owner earnings: 1105000
Return on net tangible assets (%): 0.45216466159260166
Buffett classification: The Gruesome
Stock price: 29.36
P/E ratio: 32.966594790636336
Shares outstanding: 6811150
Book value: 261946000
P/B ratio: 0.763422094630191
Market cap (USD): 199975364
Debt to equity: 0.12025761034717079
Effective tax rate (%): -15.436241610738255
COGS to revenue (%): 0
SG&A to revenue (%): 36.37054270927306
Free cash flow (dilution-adjusted): 2573000
Buyback yield (%): 2.740337554779998
Retained earnings: 153768000
Receivables turnover: 2.6767920691408236
Capitalized R&D asset: 0
FCF margin (%): 12.216893784720574
Revenue growth (%): 0.5442306774239748
Rule of 40 score: 12.761124462144549
Financial ratios for BPRN — quarterly report dated 2025-09-30
Total revenue: 21527000
Net income: 6466000
Capital expenditures: 234000
Operating cash flow: 4891000
Depreciation & amortization: 656000
Net tangible assets: 249250000
Owner earnings: 6888000
Return on net tangible assets (%): 2.7634904714142428
Buffett classification: The Gruesome
Stock price: 30.91
P/E ratio: 16.799604731886372
Shares outstanding: 6811150
Book value: 266607000
P/B ratio: 0.7896741139579981
Market cap (USD): 210532646.5
Debt to equity: 0.07959655973023964
Effective tax rate (%): 21.927070755856075
COGS to revenue (%): 0
SG&A to revenue (%): 35.65290100803642
Free cash flow (dilution-adjusted): 4335000
Buyback yield (%): 0.9110226047531302
Retained earnings: 158081000
Receivables turnover: 2.845228654507005
Capitalized R&D asset: 0
FCF margin (%): 20.13750174199842
Revenue growth (%): 2.2126204833578655
Rule of 40 score: 22.350122225356287
Financial ratios for BPRN — quarterly report dated 2025-12-31
Total revenue: 20748000
Net income: 6079000
Capital expenditures: 204000
Operating cash flow: 12206000
Depreciation & amortization: 652000
Net tangible assets: 253555000
Owner earnings: 6527000
Return on net tangible assets (%): 2.5741949478416912
Buffett classification: The Gruesome
Stock price: 34.03
P/E ratio: 12.454109639460535
Shares outstanding: 6811150
Book value: 270712000
P/B ratio: 0.8561993354561306
Market cap (USD): 231783434.5
Debt to equity: 0.07828984308046928
Effective tax rate (%): 23.21586459517494
COGS to revenue (%): 0
SG&A to revenue (%): 33.02486986697513
Free cash flow (dilution-adjusted): 11629000
Buyback yield (%): 0.1311569140632438
Retained earnings: 161780000
Receivables turnover: 2.661023470565602
Capitalized R&D asset: 0
FCF margin (%): 56.04877578561789
Revenue growth (%): -3.618711385701677
Rule of 40 score: 52.43006439991621
Financial ratios for BPRN — annual report dated 2025-12-31
Total revenue: 84283000
Net income: 18611000
Capital expenditures: 889000
Operating cash flow: 21490000
Depreciation & amortization: 2649000
Net tangible assets: 253555000
Owner earnings: 20371000
Return on net tangible assets (%): 8.03415432549151
Buffett classification: The Gruesome
Stock price: 34.03
P/E ratio: 12.454109639460535
Shares outstanding: 6811150
Book value: 270712000
P/B ratio: 0.8561993354561306
Market cap (USD): 231783434.5
Debt to equity: 0.07828984308046928
Effective tax rate (%): 21.41288742504856
COGS to revenue (%): 0
SG&A to revenue (%): 35.6691147681027
Free cash flow (dilution-adjusted): 19287000
Buyback yield (%): 3.39325371416912
Retained earnings: 161780000
Receivables turnover: 10.809670386045916
Capitalized R&D asset: 0
FCF margin (%): 22.8836182860126
Revenue growth (%): 12.848286850455903
Rule of 40 score: 35.7319051364685
Financial ratios for BSM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.52
Shares outstanding: 212499331
Market cap (USD): 1385495638.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSM — annual report dated 2022-12-31
Total revenue: 784284000
Gross profit: 657867000
Operating income: 603161000
Net income: 476480000
Capital expenditures: 1215000
Operating cash flow: 424983000
Depreciation & amortization: 47804000
Net tangible assets: 1209812000
Owner earnings: 523069000
Return on net tangible assets (%): 43.23556056643512
Capex to operating income (%): 0.2014387535003092
Buffett classification: The Great
Stock price: 11.79
P/E ratio: 5.25807402722045
Shares outstanding: 212499331
Book value: 1209812000
P/B ratio: 2.0708730881244355
Market cap (USD): 2505367112.49
Debt to equity: 0.00826574707475211
Current ratio: 5.641341836402681
Quick ratio: 5.641341836402681
Interest coverage ratio: 95.95307031498568
COGS to revenue (%): 16.118778401701427
SG&A to revenue (%): 6.840889269703323
Free cash flow (dilution-adjusted): 395032000
Buyback yield (%): 0.11938370169740699
Receivables turnover: 5.779670884396855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.62836881262355
FCF margin (%): 50.36848896573181
Rule of 40 score: 50.36848896573181
Financial ratios for BSM — annual report dated 2023-12-31
Total revenue: 501099000
Gross profit: 387051000
Operating income: 332406000
Net income: 422549000
Capital expenditures: 19740000
Operating cash flow: 521251000
Depreciation & amortization: 45683000
Net tangible assets: 1217345000
Owner earnings: 448492000
Return on net tangible assets (%): 36.84181559048586
Capex to operating income (%): 5.9385209653255355
Buffett classification: The Great
Stock price: 12.48
P/E ratio: 6.276175427891204
Shares outstanding: 212499331
Book value: 1217345000
P/B ratio: 2.178504574200412
Market cap (USD): 2651991650.88
Debt to equity: 0
Current ratio: 7.475112246477783
Quick ratio: 7.475112246477783
Interest coverage ratio: 120.69934640522875
COGS to revenue (%): 22.75957445534715
SG&A to revenue (%): 10.268429990880046
Free cash flow (dilution-adjusted): 490609000
Buyback yield (%): 0.20724047144629146
Receivables turnover: 6.0921668510571045
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.78429843164809
FCF margin (%): 97.90660129036378
Revenue growth (%): -36.10745597258136
Rule of 40 score: 61.79914531778242
Financial ratios for BSM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.78
Shares outstanding: 212499331
Market cap (USD): 2715741450.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.67
Shares outstanding: 212499331
Market cap (USD): 2692366523.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSM — annual report dated 2024-12-31
Total revenue: 439429000
Gross profit: 334951000
Operating income: 278836000
Net income: 271326000
Capital expenditures: 112236000
Operating cash flow: 389043000
Depreciation & amortization: 45196000
Net tangible assets: 1129439000
Owner earnings: 204286000
Return on net tangible assets (%): 18.08738674687168
Capex to operating income (%): 40.251617438207404
Buffett classification: The Good
Stock price: 12.67
P/E ratio: 9.922994935133381
Shares outstanding: 212499331
Book value: 1129439000
P/B ratio: 2.3838087083676056
Market cap (USD): 2692366523.77
Debt to equity: 0.022766169753302302
Current ratio: 2.581730927258982
Quick ratio: 2.581730927258982
Interest coverage ratio: 89.68671598584754
COGS to revenue (%): 23.775854574914263
SG&A to revenue (%): 11.852199103837025
Free cash flow (dilution-adjusted): 265448000
Buyback yield (%): 0.16524496054758045
Receivables turnover: 6.181044547283136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.461505128807058
FCF margin (%): 60.407483347708045
Revenue growth (%): -12.306949325382808
Rule of 40 score: 48.100534022325235
Financial ratios for BSM — quarterly report dated 2025-03-31
Total revenue: 115253000
Gross profit: 93776000
Operating income: 73162000
Net income: 15948000
Capital expenditures: 13067000
Operating cash flow: 64835000
Depreciation & amortization: 9130000
Net tangible assets: 1064965000
Owner earnings: 12011000
Return on net tangible assets (%): 1.1278304920818993
Capex to operating income (%): 17.860364670183976
Buffett classification: The Great
Stock price: 13.58
P/E ratio: 45.23672114026837
Shares outstanding: 212499331
Book value: 1064965000
P/B ratio: 2.709704933946186
Market cap (USD): 2885740914.98
Debt to equity: 0.05915687370007465
Current ratio: 1.3512673728035267
Quick ratio: 1.3512673728035267
Interest coverage ratio: 52.370794559770935
COGS to revenue (%): 18.63465593086514
SG&A to revenue (%): 13.164082496767978
Free cash flow (dilution-adjusted): 48313000
Buyback yield (%): 0.11397419577504916
Receivables turnover: 1.4787969770455625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.2344962049521815
FCF margin (%): 41.91908236661953
Rule of 40 score: 41.91908236661953
Financial ratios for BSM — quarterly report dated 2025-06-30
Total revenue: 106710000
Gross profit: 85507000
Operating income: 69497000
Net income: 120028000
Capital expenditures: 29620000
Operating cash flow: 80476000
Depreciation & amortization: 9187000
Net tangible assets: 1102616000
Owner earnings: 99595000
Return on net tangible assets (%): 9.032609720881975
Capex to operating income (%): 42.620544771716766
Buffett classification: The Good
Stock price: 11.96
P/E ratio: 18.69073953315291
Shares outstanding: 212499331
Book value: 1102616000
P/B ratio: 2.3049656442133983
Market cap (USD): 2541491998.76
Debt to equity: 0.08978647144608821
Current ratio: 3.2223180704599566
Quick ratio: 3.2223180704599566
Interest coverage ratio: 30.615418502202644
COGS to revenue (%): 19.869740417955207
SG&A to revenue (%): 13.0484490675663
Free cash flow (dilution-adjusted): 48896000
Buyback yield (%): 0
Receivables turnover: 1.3334582942830366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.609536785620885
FCF margin (%): 45.821385062318434
Revenue growth (%): -7.412388397698975
Rule of 40 score: 38.40899666461946
Financial ratios for BSM — quarterly report dated 2025-09-30
Total revenue: 105183000
Gross profit: 81595000
Operating income: 66813000
Net income: 91729000
Capital expenditures: 20704000
Operating cash flow: 99756000
Depreciation & amortization: 9900000
Net tangible assets: 1125213000
Owner earnings: 80925000
Return on net tangible assets (%): 7.191971653366963
Capex to operating income (%): 30.987981380868995
Buffett classification: The Good
Stock price: 12.31
P/E ratio: 11.487963657407612
Shares outstanding: 212499331
Book value: 1125213000
P/B ratio: 2.3247747445239257
Market cap (USD): 2615866764.61
Debt to equity: 0.08442845932281266
Current ratio: 4.367846153846154
Quick ratio: 4.367846153846154
Interest coverage ratio: 27.540395713107998
COGS to revenue (%): 22.425677153152126
SG&A to revenue (%): 11.681545496895886
Free cash flow (dilution-adjusted): 76844000
Buyback yield (%): 0.017814362960090438
Receivables turnover: 1.6341137539422375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.341279739063699
FCF margin (%): 73.05743323540877
Revenue growth (%): -1.4309811639021648
Rule of 40 score: 71.6264520715066
Financial ratios for BSM — quarterly report dated 2025-12-31
Total revenue: 95182000
Gross profit: 75398000
Operating income: 51333000
Net income: 72227000
Capital expenditures: 54883000
Operating cash flow: 65100000
Depreciation & amortization: 8670000
Net tangible assets: 1128456000
Owner earnings: 26014000
Return on net tangible assets (%): 2.3052737545814814
Capex to operating income (%): 106.91562932226833
Buffett classification: The Gruesome
Stock price: 12.74
P/E ratio: 9.026184191550085
Shares outstanding: 212499331
Book value: 1128456000
P/B ratio: 2.3990669347675055
Market cap (USD): 2707241476.94
Debt to equity: 0.13822869478296007
Current ratio: 3.884010884132721
Quick ratio: 3.884010884132721
Interest coverage ratio: 18.094113500176242
COGS to revenue (%): 20.78544262570654
SG&A to revenue (%): 14.792712907902756
Free cash flow (dilution-adjusted): 7386000
Buyback yield (%): 0.0008126353037729992
Receivables turnover: 1.4515646922466907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9157667337182502
FCF margin (%): 7.759870563762056
Revenue growth (%): -9.508190487055893
Rule of 40 score: -1.7483199232938373
Financial ratios for BSM — annual report dated 2025-12-31
Total revenue: 422328000
Gross profit: 336276000
Operating income: 260805000
Net income: 299932000
Capital expenditures: 118274000
Operating cash flow: 310167000
Depreciation & amortization: 36887000
Net tangible assets: 1128456000
Owner earnings: 218545000
Return on net tangible assets (%): 19.366727634927724
Capex to operating income (%): 45.34959069036253
Buffett classification: The Good
Stock price: 12.74
P/E ratio: 9.026184191550085
Shares outstanding: 212499331
Book value: 1128456000
P/B ratio: 2.3990669347675055
Market cap (USD): 2707241476.94
Debt to equity: 0.13822869478296007
Current ratio: 3.884010884132721
Quick ratio: 3.884010884132721
Interest coverage ratio: 29.20548712206047
COGS to revenue (%): 20.375632210035803
SG&A to revenue (%): 13.132683601371445
Free cash flow (dilution-adjusted): 181439000
Buyback yield (%): 0.13951470647048264
Receivables turnover: 6.4406758982492525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.89463976364889
FCF margin (%): 42.96163171752761
Revenue growth (%): -3.8916411980092347
Rule of 40 score: 39.06999051951838
Financial ratios for BSN.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.76136363636363
Shares outstanding: 642115656
Market cap (USD): 33878897622.81818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSN.DE — annual report dated 2022-12-31
Total revenue: 29426595744.68085
Gross profit: 13552127659.574469
Operating income: 3458510638.2978725
Net income: 1088297872.3404255
Capital expenditures: 31914893.617021278
Operating cash flow: 3153191489.3617024
Depreciation & amortization: 1981914893.6170213
Net tangible assets: -6720212765.957447
Owner earnings: 3038297872.340426
Return on net tangible assets (%): -45.211334494221944
Capex to operating income (%): 0.9227929867733005
Buffett classification: The Great
Stock price: 46.319148936170215
P/E ratio: 27.329145319882702
Shares outstanding: 642115656
Book value: 19140425531.914894
P/B ratio: 1.5538970465895954
Market cap (USD): 29742250704.51064
Debt to equity: 0.7872387727879058
Current ratio: 1.0018961253091507
Quick ratio: 0.78598516075845
Effective tax rate (%): 42.46724890829694
Interest coverage ratio: 10.555194805194805
COGS to revenue (%): 53.945988937493226
R&D to revenue (%): 1.2255522215393515
SG&A to revenue (%): 32.28733596037743
Free cash flow (dilution-adjusted): 2197872340.4255323
Buyback yield (%): 0
Retained earnings: 19059574468.085106
Inventory turnover: 5.697594501718212
Receivables turnover: 8.45385085574572
Capitalized R&D asset: 360638297.87234044
ROCI (R&D-adjusted, %): 10.38220364287847
FCF margin (%): 7.468999674632156
Rule of 40 score: 7.468999674632156
Financial ratios for BSN.DE — annual report dated 2023-12-31
Total revenue: 30687777777.77778
Gross profit: 14537777777.777777
Operating income: 3876666666.6666665
Net income: 1058888888.8888888
Capital expenditures: 16666666.666666666
Operating cash flow: 3824444444.444444
Depreciation & amortization: 1790000000
Net tangible assets: -7686666666.666666
Owner earnings: 2832222222.2222223
Return on net tangible assets (%): -36.845909222318596
Capex to operating income (%): 0.4299226139294927
Buffett classification: The Great
Stock price: 59.08888888888889
P/E ratio: 35.831805441846804
Shares outstanding: 642115656
Book value: 18024444444.444443
P/B ratio: 2.1050246940007398
Market cap (USD): 37941900651.2
Debt to equity: 0.9617186536801874
Current ratio: 0.9237591188671148
Quick ratio: 0.7563295665856101
Effective tax rate (%): 45.55160142348754
Interest coverage ratio: 6.8011695906432745
COGS to revenue (%): 52.62681487381875
R&D to revenue (%): 1.441036967305116
SG&A to revenue (%): 32.71660813208299
Free cash flow (dilution-adjusted): 2815555555.555556
Buyback yield (%): 0
Retained earnings: 18716666666.666668
Inventory turnover: 6.208885091841093
Receivables turnover: 9.461801986981845
Capitalized R&D asset: 683849881.7966903
ROCI (R&D-adjusted, %): 11.716595566267268
Rosenberg metric: 2.733071124221562
FCF margin (%): 9.174843404902424
Revenue growth (%): 4.285857745964036
Rule of 40 score: 13.46070115086646
Financial ratios for BSN.DE — annual report dated 2024-12-31
Total revenue: 28516666666.666668
Gross profit: 14173958333.333334
Operating income: 3610416666.666667
Net income: 2187500000
Capital expenditures: 18750000
Operating cash flow: 3990625000
Depreciation & amortization: 1216666666.6666667
Net tangible assets: -6471875000
Owner earnings: 3385416666.666667
Return on net tangible assets (%): -52.309673265733146
Capex to operating income (%): 0.5193306405077899
Buffett classification: The Great
Stock price: 63.38541666666667
P/E ratio: 18.606065556
Shares outstanding: 642115656
Book value: 18597916666.66667
P/B ratio: 2.188458478077741
Market cap (USD): 40700768403.75
Debt to equity: 0.7948358911168364
Current ratio: 0.9311098164870375
Quick ratio: 0.7652927468686279
Effective tax rate (%): 30.976992330776927
Interest coverage ratio: 5.776666666666667
COGS to revenue (%): 50.29587960257159
R&D to revenue (%): 1.6328170660432497
SG&A to revenue (%): 34.70192869666862
Free cash flow (dilution-adjusted): 2955208333.3333335
Buyback yield (%): 0
Retained earnings: 18277083333.333336
Inventory turnover: 6.046991655687308
Receivables turnover: 9.368925393566052
Capitalized R&D asset: 880924527.1867611
ROCI (R&D-adjusted, %): 10.822435501733064
Rosenberg metric: -0.822707286432157
FCF margin (%): 10.363091759205144
Revenue growth (%): -7.074839784206523
Rule of 40 score: 3.288251974998621
Financial ratios for BSN.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -6471875000
Buffett classification: The Gruesome
Stock price: 63.38541666666667
Shares outstanding: 642115656
Book value: 18597916666.66667
P/B ratio: 2.188458478077741
Market cap (USD): 40700768403.75
Debt to equity: 0.7948358911168364
Current ratio: 0.9311098164870375
Quick ratio: 0.7652927468686279
Buyback yield (%): 0
Retained earnings: 18277083333.333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BSN.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -7615294117.647059
Buffett classification: The Gruesome
Stock price: 78.84705882352941
Shares outstanding: 642115656
Book value: 18729411764.705883
P/B ratio: 2.703177843286432
Market cap (USD): 50628930900.141174
Debt to equity: 0.9131909547738694
Current ratio: 0.9471944770857814
Quick ratio: 0.779891304347826
Buyback yield (%): 0
Retained earnings: 20269411764.705883
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BUY.AX — annual report dated 2021-06-30
Total revenue: 1105427.819548872
Gross profit: 391563.9097744361
Operating income: -724568.4210526316
Net income: -2186146.616541353
Capital expenditures: 37087.96992481203
Depreciation & amortization: 69828.57142857142
Net tangible assets: 6357396.992481203
Owner earnings: -2153406.015037594
Return on net tangible assets (%): -33.872448387042596
Buffett classification: The Gruesome
Stock price: 0.3458646616541353
Shares outstanding: 984788366
Book value: 6357396.992481202
P/B ratio: 53.57593609622703
Market cap (USD): 340603495.00751877
Debt to equity: 0
Current ratio: 1.1596807114498295
Quick ratio: 1.1357069085334628
COGS to revenue (%): 64.57806626087678
SG&A to revenue (%): 39.19803784334171
Free cash flow (dilution-adjusted): -754605.2631578947
Buyback yield (%): 0.002207492613167468
Retained earnings: -27523627.81954887
Inventory turnover: 26.236293799049406
Receivables turnover: 6.025487704918032
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.80810664222908
FCF margin (%): -68.26363963463947
Rule of 40 score: -68.26363963463947
Financial ratios for BUY.AX — annual report dated 2022-06-30
Total revenue: 1310048.9655172415
Gross profit: 665175.1724137932
Operating income: -592608.9655172414
Net income: -1712243.448275862
Capital expenditures: 545568.275862069
Depreciation & amortization: 70461.37931034483
Net tangible assets: 5889088.9655172415
Owner earnings: -2187350.3448275863
Return on net tangible assets (%): -37.142423176748025
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 984788366
Book value: 5889088.9655172415
P/B ratio: 23.065176781046514
Market cap (USD): 135832878.06896552
Debt to equity: 0
Current ratio: 1.6914623889097191
Quick ratio: 1.6637037524954146
COGS to revenue (%): 49.22516715616316
SG&A to revenue (%): 51.58496313114909
Free cash flow (dilution-adjusted): -676037.2413793104
Buyback yield (%): 0.08854999003917964
Retained earnings: -26958053.79310345
Inventory turnover: 17.067938304280368
Receivables turnover: 86.01960784313727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.709988932124906
FCF margin (%): -51.60396742211793
Revenue growth (%): 18.510584078829847
Rule of 40 score: -33.09338334328808
Financial ratios for BUY.AX — annual report dated 2023-06-30
Total revenue: 1171488.0794701986
Gross profit: 431774.8344370861
Operating income: -550465.5629139072
Net income: -1927939.7350993378
Capital expenditures: 6816.556291390729
Depreciation & amortization: 68321.85430463577
Net tangible assets: 3727145.695364238
Owner earnings: -1866434.4370860928
Return on net tangible assets (%): -50.07677696655467
Buffett classification: The Gruesome
Stock price: 0.13245033112582782
Shares outstanding: 984788366
Book value: 3727145.6953642387
P/B ratio: 34.99609508901047
Market cap (USD): 130435545.16556293
Debt to equity: 0
Current ratio: 0.9106189519324176
Quick ratio: 0.8842243048994262
COGS to revenue (%): 63.14304498665025
SG&A to revenue (%): 33.85059020988193
Free cash flow (dilution-adjusted): -1292620.5298013245
Buyback yield (%): 0
Retained earnings: -27814812.582781456
Inventory turnover: 25.597373728114402
Receivables turnover: 13.968201451346719
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.054374429968064
FCF margin (%): -110.3400497584156
Revenue growth (%): -10.576771532530882
Rule of 40 score: -120.91682129094649
Financial ratios for BUY.AX — annual report dated 2024-06-30
Total revenue: 1075303.3333333333
Gross profit: 452726
Operating income: -643211.3333333334
Net income: -617374
Capital expenditures: 200863.33333333334
Depreciation & amortization: 85598.66666666667
Net tangible assets: 3883134.6666666665
Owner earnings: -732638.6666666667
Return on net tangible assets (%): -18.867196982781266
Buffett classification: The Gruesome
Stock price: 0.08
Shares outstanding: 984788366
Book value: 3883134.6666666665
P/B ratio: 20.28852358798785
Market cap (USD): 78783069.28
Debt to equity: 0
Current ratio: 0.6198440948035187
Quick ratio: 0.6089852836405039
COGS to revenue (%): 57.89783347954531
SG&A to revenue (%): 39.52379328623552
Free cash flow (dilution-adjusted): -419510.6666666667
Buyback yield (%): 0.024816668748772225
Retained earnings: -28617618.666666668
Inventory turnover: 29.844555942603304
Receivables turnover: 9.176039231079935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.186073661595177
FCF margin (%): -39.01323967500644
Revenue growth (%): -8.210475874442064
Rule of 40 score: -47.2237155494485
Financial ratios for CCLD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.32
Shares outstanding: 42492949
Market cap (USD): 268555437.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCLD — annual report dated 2022-12-31
Total revenue: 138826000
Gross profit: 54392000
Operating income: 4658000
Net income: 5432000
Capital expenditures: 2588000
Operating cash flow: 21151000
Depreciation & amortization: 15604000
Net tangible assets: 10983000
Owner earnings: 18448000
Return on net tangible assets (%): 167.96867886734043
Capex to operating income (%): 55.56032632030915
Buffett classification: The Good
Stock price: 2.81
P/E ratio: 21.98180903718704
Shares outstanding: 42492949
Book value: 101689000
P/B ratio: 1.1742193028744505
Market cap (USD): 119405186.69
Debt to equity: 0.13582590053988142
Current ratio: 1.547147066702384
Quick ratio: 1.5301366193410126
Effective tax rate (%): 3.155642717061865
Interest coverage ratio: 11.501234567901234
COGS to revenue (%): 60.820019304741194
R&D to revenue (%): 3.1701554463861235
SG&A to revenue (%): 24.20872170918992
Free cash flow (dilution-adjusted): 4470000
Buyback yield (%): 16.75387858312807
Retained earnings: -25621000
Inventory turnover: 221.61154855643045
Receivables turnover: 7.235042735042735
Capitalized R&D asset: 4401000
ROCI (R&D-adjusted, %): 6.424261912216421
FCF margin (%): 3.219857951680521
Rule of 40 score: 3.219857951680521
Financial ratios for CCLD — annual report dated 2023-12-31
Total revenue: 117059000
Gross profit: 46242000
Operating income: -4010000
Net income: -48674000
Capital expenditures: 3063000
Operating cash flow: 15461000
Depreciation & amortization: 17041000
Net tangible assets: -2543000
Owner earnings: -34696000
Buffett classification: The Gruesome
Stock price: 1.52
Shares outstanding: 42492949
Book value: 41717000
P/B ratio: 1.5482724663806122
Market cap (USD): 64589282.480000004
Debt to equity: 0.3531653762255196
Current ratio: 0.9975536480686695
Quick ratio: 0.9775965665236052
Interest coverage ratio: -3.358458961474037
COGS to revenue (%): 60.496843472095264
R&D to revenue (%): 4.04582304649792
SG&A to revenue (%): 26.579758924986546
Free cash flow (dilution-adjusted): -1038000
Buyback yield (%): 0
Retained earnings: -74481000
Inventory turnover: 152.29462365591397
Receivables turnover: 6.886633721614308
Capitalized R&D asset: 7684670
ROCI (R&D-adjusted, %): -3.7287279925881953
Rosenberg metric: -1.8518518518518519
FCF margin (%): -0.8867323315592991
Revenue growth (%): -15.679339604973134
Rule of 40 score: -16.56607193653243
Financial ratios for CCLD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 42492949
Market cap (USD): 112181385.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCLD — annual report dated 2024-12-31
Total revenue: 110837000
Gross profit: 49995000
Operating income: 9717000
Net income: 7851000
Capital expenditures: 1697000
Operating cash flow: 20642000
Depreciation & amortization: 16463000
Net tangible assets: 11890000
Owner earnings: 22617000
Return on net tangible assets (%): 190.21867115222878
Capex to operating income (%): 17.464237933518575
Buffett classification: The Great
Stock price: 3.66
P/E ratio: 19.809475651509363
Shares outstanding: 42492949
Book value: 49774000
P/B ratio: 3.124607090850645
Market cap (USD): 155524193.34
Debt to equity: 0.06971511230763049
Current ratio: 1.2665985699693565
Quick ratio: 1.237282941777324
Effective tax rate (%): 1.9972537760579203
Interest coverage ratio: 10.796666666666667
COGS to revenue (%): 54.893221577632026
R&D to revenue (%): 3.4113157158710536
SG&A to revenue (%): 20.169257558396563
Free cash flow (dilution-adjusted): 13121000
Buyback yield (%): 0
Retained earnings: -66630000
Inventory turnover: 105.99651567944251
Receivables turnover: 6.472611539359963
Capitalized R&D asset: 8406450
ROCI (R&D-adjusted, %): 15.20835797880393
Rosenberg metric: 0.7924408783783784
FCF margin (%): 11.838104604058211
Revenue growth (%): -5.315268368942157
Rule of 40 score: 6.522836235116054
Financial ratios for CCLD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 42492949
Market cap (USD): 155524193.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0